Skip to content
Screener

Eton Pharmaceuticals, Inc. ETON Price / earnings

Price / earnings at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
83.3×—
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
17.4×—
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
14.5×-175×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
1.4×-7.3×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
19.8×-16.3×
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
11.4×-5.5×

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K—
Free cash flow$7.3M+251%

Valuation

See full
Market cap$1.26B+209%
Enterprise value$1.28B+208%
P/S14.6×+7.5×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%—
Net margin-9.5%-2.7pp
FCF margin17.1%—

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity1×-0.2×
Current ratio1.2×-0.8×

Where this comes from

Calculated from Eton Pharmaceuticals, Inc.’s reported figures.

market cap/net income=105.5×

Based on the most recent quarter.

The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 9, 2024. Open the filing →

Filed
May 9, 2024
Fiscal quarter
Q1 FY2024
Calendar quarter
Q1 2024
Accession
0001437749-24-015697

FAQ

What is Eton Pharmaceuticals, Inc.'s price / earnings?
Eton Pharmaceuticals, Inc. (ETON) reported price / earnings of 105.5× in Q1 2024.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Ask your AI about Eton Pharmaceuticals, Inc.'s price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude